Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...

This further establishes the global leadership of AGC Biologics' Milan Cell and Gene Center of Excellence in number of commercial products approvedMILAN--(BUSINESS WIRE)--#CGT--With the decision by ...

With the decision by the U.S. Food and Drug Administration and the European Commission to grant market authorization for Waskyratm, a gene therapy to treat Wiskott-Aldrich syndrome, AGC Biologics' ...

Analysing today’s increasingly large and heterogeneous biotherapeutics remains a major challenge for drug developers, ...

In recent years, messenger RNA (mRNA) vaccines have shown significant success in preventing viral and bacterial infections, ...

Asimov’s LV Edge Packaging cell line routinely achieves high titers for therapeutic transgenes and is now available at AGC Biologics’ Cell and Gene Center of ExcellenceBOSTON & MILAN--(BUSINESS WIRE)- ...

EDINBURGH, Scotland, TORONTO and EDMONTON, AB, Jan. 6, 2026 /PRNewswire/ -- Chromatin Bioscience, Mediphage Bioceuticals, and Entos Pharmaceuticals are pleased to announce they are receiving ...

Chromatin Bioscience, Mediphage Bioceuticals, and Entos Pharmaceuticals are pleased to announce they are receiving advisory ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Been targeted by a scam? Get free assistance from the AARP Fraud ...

A Stanford-led study probes why a very small number of people develop heart inflammation shortly after mRNA COVID-19 vaccination, revealing an unexpected interaction between key immune pathways.